Bacterial Toxin Leads to CRISPR-Free Mitochondrial DNA Base Editing

Jul 08, 2020

|

NEW YORK – Researchers from the Broad Institute and the University of Washington School of Medicine have discovered a bacterial toxin that allows for base editing of mi

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Analysis for the Long Term

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

Pricey, But Available

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Pilot Cancer Testing Program for Taiwan

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

PLOS Papers on TB Resistance, Squamous Cell Carcinoma Risk, MicroRNAs in SCC

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.

Featured White Papers

Compatibility of Liquid Biopsy Assays on Multiple Sequencing Platforms

CAS-CLOVER The clean alternative to CRISPR/Cas9 for gene editing in the drug discovery and development industry

Mar

09

Featured Webinar

Implementation of Whole-Exome and Virtual Panel Testing for Rare Disease at a Children’s Hospital

The growth of next-generation sequencing (NGS) testing presents both opportunities and challenges for clinical, informatics, and laboratory teams.

Mar

11

Featured Webinar

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.

Mar

24

Featured Webinar

Single-Cell Analysis and Genome Editing in Preclinical Disease Modeling: Detailed Insights into Leukemia Lineage

This webinar, the first in a “Women in Single Cell” series sponsored by Mission Bio, will discuss the use of single-cell analysis to assess genome editing for use in pre-clinical disease modeling.

Apr

21

Featured Webinar

Single-cell Multiomics Analysis of Clonal Evolution in Myeloid Malignancies

This webinar, the first in a “Meet the Authors” series sponsored by Mission Bio, will discuss the application of single-cell analysis to decipher clonal evolution across several stages of disease development in myeloid malignancies.

Menu

Bacterial Toxin Leads to CRISPR-Free Mitochondrial DNA Base Editing

To read the full story....

Breaking News

Illumina Inks $750M Credit Facility With Bank of America

Castle Biosciences Q4 Revenues Down 2 Percent

CRISPR Screens Identify Host Factors Required for SARS-CoV-2 Infection

Case-Case GWAS Approach Identifies Loci That Differ in Frequency Across Psychiatric Disorders

Top Five Articles on GenomeWeb Last Week: Agilent, Hologic, Bio-Techne, and More

Bio-Rad Laboratories, Roche Enter Quality Control Partnership

The Scan

Analysis for the Long Term

Pricey, But Available

Pilot Cancer Testing Program for Taiwan

PLOS Papers on TB Resistance, Squamous Cell Carcinoma Risk, MicroRNAs in SCC

Featured White Papers

Implementation of Whole-Exome and Virtual Panel Testing for Rare Disease at a Children’s Hospital

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

Single-Cell Analysis and Genome Editing in Preclinical Disease Modeling: Detailed Insights into Leukemia Lineage

Single-cell Multiomics Analysis of Clonal Evolution in Myeloid Malignancies

What's Popular?

CRISPR Screens Identify Host Factors Required for SARS-CoV-2 Infection

Sponsorships